(S)-1-((3,5-bis((1,3-dihydroxypropan-2-yl)carbamoyl)-2,4,6-triiodophenyl)amino)-1-oxopropan-2-ylacetate;(S)-5-[[2-(Acetyloxy)-1-oxopropyl]amino]-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,?3-?benzenedicarboxamide;5-?[[(2S)?-?2-?(Acetyloxy)?-?1-?oxopropyl]?amino]?-?N,?N'-?bis[2-?hydroxy-?1-?(hydroxymethyl)?ethyl]?-?2,?4,?6-?triiodo-1,?3-?benzenedicarboxamide?(Iopamidol EP Impurity E)
Iopamidol EP Impurity E is a fully characterized chemical compound used as a reference standard of API Iopamidol. The standard offered is compliant with regulatory guidelines. Iopamidol EP Impurity E is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 60166-92-9
